Mark L. Hartman

1 ta ish

Institute of Endocrinology

1. Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial

   Ania M. Jastreboff, Lee M. Kaplan, Juan P. Frías +7

   Maqola20232 iqtibos

   ABIABI:AkademIndex/2026.other.057851